Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 83 entries
Sorted by: Best Match Show Resources per page
Prevention of stress ulcer bleeding: a review.

Scandinavian journal of gastroenterology. Supplement

Geus WP, Lamers CB.
PMID: 2277967
Scand J Gastroenterol Suppl. 1990;178:32-41. doi: 10.3109/00365529009093148.

The pathophysiology of stress ulcers is complex. There is either too much acid and pepsin or inadequate mucosal defenses. The incidence of upper GI bleeding due to stress ulcers in the ICU is 5-25% depending upon the minimum criterion...

Cite
Geus WP, Lamers CB. Prevention of stress ulcer bleeding: a review. Scand J Gastroenterol Suppl. 1990;178:32-41doi: 10.3109/00365529009093148.
Geus, W. P., & Lamers, C. B. (1990). Prevention of stress ulcer bleeding: a review. Scandinavian journal of gastroenterology. Supplement, 17832-41. https://doi.org/10.3109/00365529009093148
Geus, W P, and Lamers, C B. "Prevention of stress ulcer bleeding: a review." Scandinavian journal of gastroenterology. Supplement vol. 178 (1990): 32-41. doi: https://doi.org/10.3109/00365529009093148
Geus WP, Lamers CB. Prevention of stress ulcer bleeding: a review. Scand J Gastroenterol Suppl. 1990;178:32-41. doi: 10.3109/00365529009093148. PMID: 2277967.
Copy Download .nbib Format: NLM
Sucralfate gel as a radioprotector against radiation induced dermatitis in a hypo-fractionated schedule: a non-randomized study.

Hippokratia

Kouloulias V, Asimakopoulos C, Tolia M, Filippou G, Platoni K, Dilvoi M, Beli I, Georgakopoulos J, Patatoukas G, Kelekis N.
PMID: 24376316
Hippokratia. 2013 Apr;17(2):126-9.

External beam radiotherapy with high doses provokes many acute skin reactions, such as erythema and moist desquamation. Many topical preparations are used in radiation oncology departments in the skin care. Sucralfate humid gel, a colloidal physical form of the...

Cite
Kouloulias V, Asimakopoulos C, Tolia M, et al. Sucralfate gel as a radioprotector against radiation induced dermatitis in a hypo-fractionated schedule: a non-randomized study. Hippokratia. 2013;17(2):126-9
Kouloulias, V., Asimakopoulos, C., Tolia, M., Filippou, G., Platoni, K., Dilvoi, M., Beli, I., Georgakopoulos, J., Patatoukas, G., & Kelekis, N. (2013). Sucralfate gel as a radioprotector against radiation induced dermatitis in a hypo-fractionated schedule: a non-randomized study. Hippokratia, 17(2), 126-9.
Kouloulias, V, et al. "Sucralfate gel as a radioprotector against radiation induced dermatitis in a hypo-fractionated schedule: a non-randomized study." Hippokratia vol. 17,2 (2013): 126-9.
Kouloulias V, Asimakopoulos C, Tolia M, Filippou G, Platoni K, Dilvoi M, Beli I, Georgakopoulos J, Patatoukas G, Kelekis N. Sucralfate gel as a radioprotector against radiation induced dermatitis in a hypo-fractionated schedule: a non-randomized study. Hippokratia. 2013 Apr;17(2):126-9. PMID: 24376316; PMCID: PMC3743615.
Copy Download .nbib Format: NLM
Pelvic radiation disease: Updates on treatment options.

World journal of clinical oncology

Frazzoni L, La Marca M, Guido A, Morganti AG, Bazzoli F, Fuccio L.
PMID: 26677440
World J Clin Oncol. 2015 Dec 10;6(6):272-80. doi: 10.5306/wjco.v6.i6.272.

Pelvic cancers are among the most frequently diagnosed neoplasms and radiotherapy represents one of the main treatment options. The irradiation field usually encompasses healthy intestinal tissue, especially of distal large bowel, thus inducing gastrointestinal (GI) radiation-induced toxicity. Indeed, up...

Cite
Frazzoni L, La Marca M, Guido A, et al. Pelvic radiation disease: Updates on treatment options. World J Clin Oncol. 2015;6(6):272-80doi: 10.5306/wjco.v6.i6.272.
Frazzoni, L., La Marca, M., Guido, A., Morganti, A. G., Bazzoli, F., & Fuccio, L. (2015). Pelvic radiation disease: Updates on treatment options. World journal of clinical oncology, 6(6), 272-80. https://doi.org/10.5306/wjco.v6.i6.272
Frazzoni, Leonardo, et al. "Pelvic radiation disease: Updates on treatment options." World journal of clinical oncology vol. 6,6 (2015): 272-80. doi: https://doi.org/10.5306/wjco.v6.i6.272
Frazzoni L, La Marca M, Guido A, Morganti AG, Bazzoli F, Fuccio L. Pelvic radiation disease: Updates on treatment options. World J Clin Oncol. 2015 Dec 10;6(6):272-80. doi: 10.5306/wjco.v6.i6.272. PMID: 26677440; PMCID: PMC4675912.
Copy Download .nbib Format: NLM
Sucralfate and Lidocain: Antacid 50:50 solution in Post Esophageal Variceal Band Ligation Pain.

Pakistan journal of medical sciences

Hafeez M, Kadir E, Aijaz A.
PMID: 27648035
Pak J Med Sci. 2016 Jul-Aug;32(4):896-89. doi: 10.12669/pjms.324.9645.

OBJECTIVE: To compare the effectiveness of pain relief of Sucralfate and lidocain antacid 50:50 solution in post esophageal variceal band ligation pain.METHODS: All patients who had under gone Esophageal Variceal Band Ligation (EVBL) were included in the study. Patients...

Cite
Hafeez M, Kadir E, Aijaz A. Sucralfate and Lidocain: Antacid 50:50 solution in Post Esophageal Variceal Band Ligation Pain. Pak J Med Sci. 2016;32(4):896-89doi: 10.12669/pjms.324.9645.
Hafeez, M., Kadir, E., & Aijaz, A. (2016). Sucralfate and Lidocain: Antacid 50:50 solution in Post Esophageal Variceal Band Ligation Pain. Pakistan journal of medical sciences, 32(4), 896-89. https://doi.org/10.12669/pjms.324.9645
Hafeez, Muhammad, et al. "Sucralfate and Lidocain: Antacid 50:50 solution in Post Esophageal Variceal Band Ligation Pain." Pakistan journal of medical sciences vol. 32,4 (2016): 896-89. doi: https://doi.org/10.12669/pjms.324.9645
Hafeez M, Kadir E, Aijaz A. Sucralfate and Lidocain: Antacid 50:50 solution in Post Esophageal Variceal Band Ligation Pain. Pak J Med Sci. 2016 Jul-Aug;32(4):896-89. doi: 10.12669/pjms.324.9645. PMID: 27648035; PMCID: PMC5017098.
Copy Download .nbib Format: NLM
Duodenogastric Reflux-induced (Alkaline) Esophagitis.

Current treatment options in gastroenterology

Richter JE.
PMID: 14723838
Curr Treat Options Gastroenterol. 2004 Feb;7(1):53-58. doi: 10.1007/s11938-004-0025-1.

Duodenogastric reflux is the retrograde flow of duodenal contents into the stomach that then mix with acid and pepsin. These agents can reflux into the esophagus (ie, duodenogastroesophageal reflux ) and cause gastroesophageal reflux disease (GERD) and its complications,...

Cite
Richter JE. Duodenogastric Reflux-induced (Alkaline) Esophagitis. Curr Treat Options Gastroenterol. 2004;7(1):53-58doi: 10.1007/s11938-004-0025-1.
Richter, J. E. (2004). Duodenogastric Reflux-induced (Alkaline) Esophagitis. Current treatment options in gastroenterology, 7(1), 53-58. https://doi.org/10.1007/s11938-004-0025-1
Richter, Joel E.. "Duodenogastric Reflux-induced (Alkaline) Esophagitis." Current treatment options in gastroenterology vol. 7,1 (2004): 53-58. doi: https://doi.org/10.1007/s11938-004-0025-1
Richter JE. Duodenogastric Reflux-induced (Alkaline) Esophagitis. Curr Treat Options Gastroenterol. 2004 Feb;7(1):53-58. doi: 10.1007/s11938-004-0025-1. PMID: 14723838.
Copy Download .nbib Format: NLM
Black esophagus associated with alcohol abuse.

Gut and liver

Hong JW, Kim SU, Park HN, Seo JH, Lee YC, Kim H.
PMID: 20485624
Gut Liver. 2008 Sep;2(2):133-5. doi: 10.5009/gnl.2008.2.2.133. Epub 2008 Sep 30.

Black esophagus is a rare condition of the esophagus that manifests as endoscopic findings of black-colored esophageal mucosa, which is usually caused by acute esophageal necrosis. We report a case of alcoholic patient who developed black esophagus. The 85-year-old...

Cite
Hong JW, Kim SU, Park HN, et al. Black esophagus associated with alcohol abuse. Gut Liver. 2008;2(2):133-5doi: 10.5009/gnl.2008.2.2.133.
Hong, J. W., Kim, S. U., Park, H. N., Seo, J. H., Lee, Y. C., & Kim, H. (2008). Black esophagus associated with alcohol abuse. Gut and liver, 2(2), 133-5. https://doi.org/10.5009/gnl.2008.2.2.133
Hong, Jae Won, et al. "Black esophagus associated with alcohol abuse." Gut and liver vol. 2,2 (2008): 133-5. doi: https://doi.org/10.5009/gnl.2008.2.2.133
Hong JW, Kim SU, Park HN, Seo JH, Lee YC, Kim H. Black esophagus associated with alcohol abuse. Gut Liver. 2008 Sep;2(2):133-5. doi: 10.5009/gnl.2008.2.2.133. Epub 2008 Sep 30. PMID: 20485624; PMCID: PMC2871582.
Copy Download .nbib Format: NLM
Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study.

Journal of neurogastroenterology and motility

Kim EJ, Lee OY, Lee KN, Lee SJ, Jang JY, Cho JW, Kim TO.
PMID: 31327222
J Neurogastroenterol Motil. 2019 Jul 01;25(3):403-412. doi: 10.5056/jnm18185.

BACKGROUND/AIMS: Proton pump inhibitors (PPIs) are frequently used to treat non-erosive reflux disease (NERD), but their effect is limited. It is not known whether a potential alternative, AlbisD, containing ranitidine hydrochloride, sucralfate hydrate, and tripotassium dicitrato bismuthate, is effective...

Cite
Kim EJ, Lee OY, Lee KN, et al. Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study. J Neurogastroenterol Motil. 2019;25(3):403-412doi: 10.5056/jnm18185.
Kim, E. J., Lee, O. Y., Lee, K. N., Lee, S. J., Jang, J. Y., Cho, J. W., & Kim, T. O. (2019). Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study. Journal of neurogastroenterology and motility, 25(3), 403-412. https://doi.org/10.5056/jnm18185
Kim, Eun Jin, et al. "Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study." Journal of neurogastroenterology and motility vol. 25,3 (2019): 403-412. doi: https://doi.org/10.5056/jnm18185
Kim EJ, Lee OY, Lee KN, Lee SJ, Jang JY, Cho JW, Kim TO. Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study. J Neurogastroenterol Motil. 2019 Jul 01;25(3):403-412. doi: 10.5056/jnm18185. PMID: 31327222; PMCID: PMC6657924.
Copy Download .nbib Format: NLM
Acid suppression therapy and allergic reactions.

Allergo journal international

Untersmayr E.
PMID: 28603686
Allergo J Int. 2015 Dec;24(8):303-311. doi: 10.1007/s40629-015-0085-x.

The development of pharmaceutical agents such as sucralfate, histamine 2 (H2) receptor blockers and proton pump inhibitors (PPIs) reducing gastric acidity has been a mile stone for treatment of dyspeptic disorders. However, due to current prescription habits resulting in...

Cite
Untersmayr E. Acid suppression therapy and allergic reactions. Allergo J Int. 2015;24(8):303-311doi: 10.1007/s40629-015-0085-x.
Untersmayr, E. (2015). Acid suppression therapy and allergic reactions. Allergo journal international, 24(8), 303-311. https://doi.org/10.1007/s40629-015-0085-x
Untersmayr, Eva. "Acid suppression therapy and allergic reactions." Allergo journal international vol. 24,8 (2015): 303-311. doi: https://doi.org/10.1007/s40629-015-0085-x
Untersmayr E. Acid suppression therapy and allergic reactions. Allergo J Int. 2015 Dec;24(8):303-311. doi: 10.1007/s40629-015-0085-x. PMID: 28603686; PMCID: PMC5464390.
Copy Download .nbib Format: NLM
EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery

Fernandez OOA, Pereira JA, Campos FG, Araya CM, Marinho GE, Novo RS, Oliveira TS, Franceschi YT, Martinez CAR.
PMID: 30133683
Arq Bras Cir Dig. 2018 Aug 16;31(3):e1391. doi: 10.1590/0102-672020180001e1391.

BACKGROUND: The effects of topical application of sucralfate (SCF) on the tissue content of MUC-2 protein have not yet been evaluated in experimental models of diversion colitis.AIM: To measure the tissue content of MUC-2 protein in the colonic mucosa...

Cite
Fernandez OOA, Pereira JA, Campos FG, et al. EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS. Arq Bras Cir Dig. 2018;31(3):e1391doi: 10.1590/0102-672020180001e1391.
Fernandez, O. O. A., Pereira, J. A., Campos, F. G., Araya, C. M., Marinho, G. E., Novo, R. S., Oliveira, T. S., Franceschi, Y. T., & Martinez, C. A. R. (2018). EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS. Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery, 31(3), e1391. https://doi.org/10.1590/0102-672020180001e1391
Fernandez, Oscar Orlando Araya, et al. "EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS." Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery vol. 31,3 (2018): e1391. doi: https://doi.org/10.1590/0102-672020180001e1391
Fernandez OOA, Pereira JA, Campos FG, Araya CM, Marinho GE, Novo RS, Oliveira TS, Franceschi YT, Martinez CAR. EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS. Arq Bras Cir Dig. 2018 Aug 16;31(3):e1391. doi: 10.1590/0102-672020180001e1391. Portuguese. PMID: 30133683; PMCID: PMC6097158.
Copy Download .nbib Format: NLM
Gastroprotective Effect of DLBS2411 Bioactive Fraction from .

Journal of experimental pharmacology

Tjandrawinata RR, Nailufar F.
PMID: 32256127
J Exp Pharmacol. 2020 Mar 20;12:87-95. doi: 10.2147/JEP.S244223. eCollection 2020.

BACKGROUND: The study was carried out to evaluate the anti-ulcerative and gastroprotective effect of DLBS2411, a bioactive fraction from METHODS: The rats were divided into five treatment groups, which were the Normal control group, Negative control group (ethanol-induced) and...

Cite
Tjandrawinata RR, Nailufar F. Gastroprotective Effect of DLBS2411 Bioactive Fraction from . J Exp Pharmacol. 2020;12:87-95doi: 10.2147/JEP.S244223.
Tjandrawinata, R. R., & Nailufar, F. (2020). Gastroprotective Effect of DLBS2411 Bioactive Fraction from . Journal of experimental pharmacology, 1287-95. https://doi.org/10.2147/JEP.S244223
Tjandrawinata, Raymond R, and Nailufar, Florensia. "Gastroprotective Effect of DLBS2411 Bioactive Fraction from ." Journal of experimental pharmacology vol. 12 (2020): 87-95. doi: https://doi.org/10.2147/JEP.S244223
Tjandrawinata RR, Nailufar F. Gastroprotective Effect of DLBS2411 Bioactive Fraction from . J Exp Pharmacol. 2020 Mar 20;12:87-95. doi: 10.2147/JEP.S244223. eCollection 2020. PMID: 32256127; PMCID: PMC7093102.
Copy Download .nbib Format: NLM
Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study.

Pharmaceutics

Walden DM, Khotimchenko M, Hou H, Chakravarty K, Varshney J.
PMID: 33919271
Pharmaceutics. 2021 Apr 21;13(5). doi: 10.3390/pharmaceutics13050594.

Fluoroquinolones (FQs) are a widespread class of broad-spectrum antibiotics prescribed as a first line of defense, and, in some cases, as the only treatment against bacterial infection. However, when administered orally, reduced absorption and bioavailability can occur due to...

Cite
Walden DM, Khotimchenko M, Hou H, et al. Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study. Pharmaceutics. 2021;13(5)doi: 10.3390/pharmaceutics13050594.
Walden, D. M., Khotimchenko, M., Hou, H., Chakravarty, K., & Varshney, J. (2021). Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study. Pharmaceutics, 13(5), . https://doi.org/10.3390/pharmaceutics13050594
Walden, Daniel M, et al. "Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study." Pharmaceutics vol. 13,5 (2021). doi: https://doi.org/10.3390/pharmaceutics13050594
Walden DM, Khotimchenko M, Hou H, Chakravarty K, Varshney J. Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study. Pharmaceutics. 2021 Apr 21;13(5). doi: 10.3390/pharmaceutics13050594. PMID: 33919271; PMCID: PMC8143323.
Copy Download .nbib Format: NLM
Epidemiology, Pathogenesis, and Clinical Manifestations of Acute Esophageal Necrosis in Adults.

Cureus

Rehman O, Jaferi U, Padda I, Khehra N, Atwal H, Parmar M.
PMID: 34447648
Cureus. 2021 Jul 25;13(7):e16618. doi: 10.7759/cureus.16618. eCollection 2021 Jul.

Acute esophageal necrosis (AEN), also termed "black esophagus," is a unique and uncommon occurrence observed in severely sick patients. Other terminologies include acute necrotizing esophagitis and Gurvits syndrome. This condition is described as a darkened distal third of the...

Cite
Rehman O, Jaferi U, Padda I, et al. Epidemiology, Pathogenesis, and Clinical Manifestations of Acute Esophageal Necrosis in Adults. Cureus. 2021;13(7):e16618doi: 10.7759/cureus.16618.
Rehman, O., Jaferi, U., Padda, I., Khehra, N., Atwal, H., & Parmar, M. (2021). Epidemiology, Pathogenesis, and Clinical Manifestations of Acute Esophageal Necrosis in Adults. Cureus, 13(7), e16618. https://doi.org/10.7759/cureus.16618
Rehman, Obaid, et al. "Epidemiology, Pathogenesis, and Clinical Manifestations of Acute Esophageal Necrosis in Adults." Cureus vol. 13,7 (2021): e16618. doi: https://doi.org/10.7759/cureus.16618
Rehman O, Jaferi U, Padda I, Khehra N, Atwal H, Parmar M. Epidemiology, Pathogenesis, and Clinical Manifestations of Acute Esophageal Necrosis in Adults. Cureus. 2021 Jul 25;13(7):e16618. doi: 10.7759/cureus.16618. eCollection 2021 Jul. PMID: 34447648; PMCID: PMC8381445.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 83 entries